Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Treatment for Advanced Pancreatic Cancer”

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation

Showing 20 of 0 results

Large-scale testing (Phase 3)Study completedNCT00051467
What this trial is testing

TNFerade™ Biologic With 5-FU and Radiation Therapy for First-Line Treatment of Unresectable Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
GenVec
Not applicableAvailableNCT07614048
What this trial is testing

Intermediate-size IND for Treatment of Patients With Advanced Cancer Using T Cells Engineered to Express TCR Targeting Mutant KRAS

Who this might be right for
PDAC - Pancreatic Ductal AdenocarcinomaColorectal Cancer
Providence Health & Services
Testing effectiveness (Phase 2)Study completedNCT05512377
What this trial is testing

Brightline-2: A Study to Test Whether Brigimadlin (BI 907828) Helps People With Cancer in the Biliary Tract, Pancreas, Lung or Bladder

Who this might be right for
Pancreatic NeoplasmsSolid TumorsBiliary Tract Cancer+2 more
Boehringer Ingelheim 99
Testing effectiveness (Phase 2)Study completedNCT02351219
What this trial is testing

FOLFOXIRI as Primary Treatment for Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Carcinoma Stage III
Azienda Ospedaliero, Universitaria Pisana 50
Testing effectiveness (Phase 2)UnknownNCT03403101
What this trial is testing

The Combination Chemotherapy of SIRIOX as First- or Second-Line Chemotherapy for Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
Fudan University 65
Early research (Phase 1)Not Yet RecruitingNCT06346808
What this trial is testing

Oncolytic Virus Plus Anti-PD1 and Chemotherapy as Preoperative Therapy for Patients With BRPC/LAPC

Who this might be right for
Pancreatic Cancer
Sichuan University 20
Testing effectiveness (Phase 2)Looking for participantsNCT05969860
What this trial is testing

At-Home Cancer Directed Therapy Versus in Clinic for the Treatment of Patients With Advanced Cancer

Who this might be right for
Advanced Anal CarcinomaAdvanced Biliary Tract CarcinomaAdvanced Bladder Carcinoma+41 more
Mayo Clinic 220
Testing effectiveness (Phase 2)Study completedNCT00602602
What this trial is testing

Bevacizumab, Combination Chemotherapy, and Radiation Therapy in Treating Patients Undergoing Surgery For Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Abramson Cancer Center at Penn Medicine 19
Large-scale testing (Phase 3)Not Yet RecruitingNCT07711067
What this trial is testing

A Study Comparing Whole-Body Heat Treatment Plus Systemic Therapy to Systemic Therapy Alone, for Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Ductal Adenocarcinoma (mPDAC)Metastatic Pancreatic Ductal Adenocarcinoma (PDAC)
ElmediX 95
Testing effectiveness (Phase 2)Study completedNCT00049348
What this trial is testing

Chemotherapy and Radiation Therapy in Treating Patients With Locally Advanced Pancreatic Cancer

Who this might be right for
Pancreatic Cancer
Eastern Cooperative Oncology Group
Testing effectiveness (Phase 2)Looking for participantsNCT07312422
What this trial is testing

LDRT Combined With Pucotenlimab and Standard Therapy for Advanced Pancreatic Cancer: A Single-Arm Study

Who this might be right for
Pancreatic CancerPD-L1PD-1 Inhibitor+2 more
Zhejiang Provincial People's Hospital 10
Testing effectiveness (Phase 2)UnknownNCT06051851
What this trial is testing

Penpulimab Combined With Anlotinib and Nab-paclitaxel Plus Gemcitabine as First-line Treatment for Advanced Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic Adenocarcinoma Metastatic
The Affiliated Nanjing Drum Tower Hospital of Nanjing University Medical School 177
Not applicableLooking for participantsNCT06984562
What this trial is testing

Adaptive Radiation for Locally Advanced Unresectable Pancreatic Cancer

Who this might be right for
Locally Advanced Pancreatic Ductal Adenocarcinoma (PDA)
Fox Chase Cancer Center 16
Early research (Phase 1)Looking for participantsNCT06126406
What this trial is testing

Clinical Study of CEA Targeting Chimeric Antigen Receptor T Lymphocytes（CAR-T） for CEA Positive Advanced Malignant Solid Tumors

Who this might be right for
Gastric CancerColon CancerRectal Cancer+5 more
Chongqing Precision Biotech Co., Ltd 60
Testing effectiveness (Phase 2)Not Yet RecruitingNCT07108504
What this trial is testing

Efficacy and Safety of LM-302 Combined With Gemcitabine CLDN 18.2 Positive Unresectable Locally Advanced or Metastatic Pancreatic Cancer

Who this might be right for
Pancreatic CancerChemotherapy Effect
Shanghai Zhongshan Hospital 30
Early research (Phase 1)Looking for participantsNCT06065371
What this trial is testing

Sacituzumab Govitecan in Combination With Capecitabine for Advanced Gastrointestinal Cancers After Progression on Standard Therapy

Who this might be right for
Gastrointestinal Cancer
Henry Ford Health System 20
Testing effectiveness (Phase 2)Study completedNCT02318784
What this trial is testing

Carfilzomib for the Treatment of Patients With Advanced Neuroendocrine Cancers

Who this might be right for
Neuroendocrine Cancer
SCRI Development Innovations, LLC 62
Testing effectiveness (Phase 2)WithdrawnNCT00226746
What this trial is testing

Efficacy Study of Gemcitabine, Paclitaxel, and Irradiation in the Treatment of Pancreatic Cancer

Who this might be right for
Carcinoma, Pancreatic Ductal
New York Presbyterian Brooklyn Methodist Hospital
Testing effectiveness (Phase 2)Study completedNCT02707159
What this trial is testing

Circulating Tumor Cells as Tools for Therapy Response in Nab-paclitaxel Treated Metastatic Pancreatic Cancer Patients

Who this might be right for
Metastatic Pancreatic Cancer
Helse Stavanger HF 70
Testing effectiveness (Phase 2)Active Not RecruitingNCT02568267
What this trial is testing

Basket Study of Entrectinib (RXDX-101) for the Treatment of Patients With Solid Tumors Harboring NTRK 1/2/3 (Trk A/B/C), ROS1, or ALK Gene Rearrangements (Fusions)

Who this might be right for
Breast CancerCholangiocarcinomaColorectal Cancer+13 more
Hoffmann-La Roche 534
Next Page